| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |